4//SEC Filing
Lynch Brian Joseph 4
Accession 0000950170-23-068575
CIK 0001157601other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:30 PM ET
Size
19.2 KB
Accession
0000950170-23-068575
Insider Transaction Report
Form 4
Lynch Brian Joseph
SVP and General Counsel
Transactions
- Sale
Common Stock
2023-12-04$215.73/sh−800$172,584→ 16,001 total - Exercise/Conversion
Common Stock
2023-12-05$87.09/sh+1,000$87,090→ 16,001 total - Sale
Common Stock
2023-12-05$227.33/sh−1,000$227,330→ 15,001 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-04−800→ 20,200 totalExercise: $73.75Exp: 2032-08-10→ Common Stock (1,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-04−1,000→ 44,000 totalExercise: $87.09Exp: 2032-02-22→ Common Stock (1,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-05−1,000→ 43,000 totalExercise: $87.09Exp: 2032-02-22→ Common Stock (800 underlying) - Sale
Common Stock
2023-12-04$221.38/sh−1,000$221,380→ 15,001 total - Exercise/Conversion
Common Stock
2023-12-04$73.75/sh+800$59,000→ 15,801 total - Exercise/Conversion
Common Stock
2023-12-04$87.09/sh+1,000$87,090→ 16,801 total
Holdings
- 530(indirect: By IRA)
Common Stock
Footnotes (2)
- [F1]All shares issued pursuant to the exercise of this option represent 800 shares underlying an overall option award of 25,000 shares. All exercised options had vested. As to the overall option for 25,000 shares, 25% of the shares underlying the option vested on August 10, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
- [F2]All shares issued pursuant to the exercise of this option represent 2,000 shares underlying an overall option award of 45,000 shares. All exercised options had vested. As to the overall option for 45,000 shares, 25% of the shares underlying the option vested on February 22, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0001776196
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:30 PM ET
- Size
- 19.2 KB